Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido® to Apotex

Grünenthal Group Germany Ontario

| Follow us on LinkedIn & Instagram

Media Contacts

Apotex

Media, [e-mail]

 

 

 

Grünenthal

Maren Thurow

Head of Global Communications

[phone]

[e-mail]

 

 

View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido-to-apotex-302680396.html